“Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia-Reference-Cited by-同舟云学术

“Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia

Published:2010-11 Issue:11 Volume:34 Page:1472-1475
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Latagliata Roberto,Breccia Massimo,Carmosino Ida,Cannella Laura,De Cuia Rosa,Diverio Daniela,Frustaci Anna,Loglisci Giuseppina,Mancini Marco,Santopietro Michelina,Stefanizzi Caterina,Volpicelli Paola,Vozella Federico,Alimena Giuliana

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. Chronic myeloid leukemia: a model for oncology;Helhmann;Ann Hematol,2005

2. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990

3. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

4. Evolving concepts in the management of chronic myeloid leukemia. Recommendations from an expert panel on behalf of the European Leukemianet;Baccarani;Blood,2006

5. IRIS Investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice of Frontline Tyrosine‐Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A “Campus CML” Study;European Journal of Haematology;2024-09-12

2. CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study;Annals of Hematology;2024-06-11

3. Challenges in management of older patients with chronic myeloid leukemia;Leukemia & Lymphoma;2024-04-23

4. CML in the Very Elderly: The Impact of Comorbidities and TKI Selection in a Real-life Multicenter Study;2024-03-13

5. Comparison of Clinicopathological Parameters, and Treatment Responses in Younger and Older Chronic Myeloid Leukaemia Patients Treated with Imatinib;NOVEMBER 2023;2023-11-13